crypto to get into, Top stories

Mei Ansen signed a strategic cooperation agreement with Shuguang Network Technology Co., Ltd. According to Mei Ansen, recently, Mei Ansen and Shuguang Network Technology Co., Ltd. held a strategic cooperation signing ceremony in Chongqing. The two sides reached a strategic cooperation to jointly build smart mine bases and comprehensive solutions. Shuguang Network Technology Co., Ltd. is a holding subsidiary of Zhongke Shuguang (603019).Citigroup: Pinduoduo, which operates retail platform Temu, is likely to continue to face short-term disadvantages. Maintain the neutral rating of ADR in Pinduoduo and set the target price of ADR in Pinduoduo at $125.00. Note: The latest ADR report in Pinduoduo is $103.42.Yamato: Raising the target price of IWC to HK$ 20 has a more positive view on next year's revenue growth. Yamato published a report that under the strong demand from Malaysia, the bank has a more positive view on IWC's revenue growth next year. In addition, the bank believes that the external financing of operating GDSI, a data center outside the mainland, will release shareholder value. However, as GDSI will be separated from IWC's consolidated statements in the fourth quarter of this year, the bank believes that IWC's short-term re-evaluation will still mainly depend on its mainland business performance, so it still maintains a wait-and-see attitude. The bank maintained its "hold" rating on IWC, and its target price was raised from HK$ 8.6 to HK$ 20. Considering the increase in capital expenditure of IWC from 2025 to 2026, the bank raised its revenue forecast for this year and next by 5% to 24%, mainly due to the strong demand in the international market driven by short video platforms. In addition, in view of the fact that the company raised its capital expenditure guideline from 6.5 billion yuan to 11 billion yuan this year, the bank raised its capital expenditure forecast from 6.7 billion yuan to 11 billion yuan in 2024 and from 3.5 billion yuan to 10.5 billion yuan in 2025. In addition, the bank will raise the adjusted EBITDA forecast of IWC this year and next by 4% to 13% to consider the EBITDA contribution of its overseas business; It is estimated that the total revenue will increase by 15% this year (10% compared with the previous forecast) and 33% next year (15% compared with the previous forecast). The adjusted EBITDA is expected to increase by 11% and 25% this year and next (8% and 15% compared with the previous forecast).

According to the Japan News Agency, Japan's House of Representatives is expected to pass an additional budget for fiscal year 2024 on Thursday.Market News: NVIDIA has increased its recruitment in China, focusing on artificial intelligence to drive cars.Home improvement stocks continued to rise, with daily limit of Wole Home, Meike Home, Yazhen Home, Mengtian Home, Jinpai Home and Double Gun Technology, while Dinggu Set rose by over 10%, while Shangpin home delivery, Fun Sleep Technology and Wrigley Home rose by over 5%.

Afternoon comments on Hong Kong stocks: Hang Seng Index rose by 1.72%, Hang Seng Technology Index rose by 2.55%, Hong Kong stocks closed at noon, Hang Seng Index rose by 1.72% and Hang Seng Technology Index rose by 2.55%. Chinese brokerage stocks and consumer stocks were among the top gainers, with China Merchants Securities, Mengniu Dairy and Tongcheng Travel up over 7% and over 5% respectively.Chief Economic Adviser of India: The growth rate will be 6.5-7% in FY 2025. The chief economic adviser of India said that maintaining the growth rate is still a top priority. The growth rate will be 6.5-7% in FY 2025.A former employee of Adebio was sentenced and involved in AstraZeneca employees' insurance fraud case. A former employee of the genetic testing company Aidebio, which worked closely with AstraZeneca, committed medical insurance fraud together with AstraZeneca sales staff during his tenure in the company. He was sentenced to three years' imprisonment and fined for fraud, and I pleaded guilty. A judgment obtained shows that Ma, a former employee of Aide Bio involved in the case, conspired with AstraZeneca employees to tamper with the genetic test report during his tenure. He began to accept public security investigation in September 2021 and was sentenced in August 2023. However, on December 9, 2024, the company replied that "there is no problem (cooperation with AstraZeneca), which has no impact on us and has nothing to do with us" and denied that any employees were involved. (financial magazine)